Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 5:17 PM
Ignite Modification Date:
2025-12-26 @ 5:17 PM
NCT ID:
NCT03674606
Eligibility Criteria:
Inclusion Criteria:
* Nulliparous women.
* Ability to speak and .read English
* Singleton pregnancy at \<14 weeks.
* Willing to sign voluntarily a statement of informed consent to participate in the study.
Exclusion Criteria:
* Presence of fetal anomaly at the time of the first trimester scan
* Women with known major risk factors for pre-eclampsia who should already be on Aspirin as per National Institute of Clinical Excellence (NICE) guidance; specifically chronic hypertension, underlying connective tissue, renal or vascular disorder, type 1 diabetes mellitus.
* Under 18 years of age.
* Currently enrolled in other clinical trials.
* Contraindications to Aspirin therapy.
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT03674606
Study Brief:
Protocol Section:
NCT03674606